Lisdexamfetamine for methamphetamine withdrawal: clinical trial A clinical trial in Australia to test lisdexamfetamine as a treatment for methamphetamine withdrawal (the OLAM trial).
The IMPACT Study A study examining a new internet delivered cognitive behavioural therapy program for Methamphetamine. IMPACT is now open for participants.
Healthy ageing for people who use methamphetamine Findings from two studies, followed by a panel discussion featuring clinicians, researchers, and people with lived/living experience
Measuring meaningful outcomes in trials of medications for methamphetamine use disorder Findings from a systematic review, and lived and living experience perspectives
Community-led approaches to drug monitoring and early warning: Lessons from the around the world NCCRED and AIVL hosted a discussion on how lived and living experience perspectives can be meaningfully embedded in drug monitoring systems.
